Following the diagnosis of DR or AMD, a patient can be started on an anti-VEGF medication and be placed on a specific dosing regimen that the patient and physician agree on, typically beginning at a treatment interval of every 4 weeks [55,56]. This evidence concerns the gene VEGFA and age-related macular degeneration.